Hanmi Pharm
Scope
Date
~
-
Electronics
Hanmi Semiconductor to retire $90 mn treasury shares in May
Hanmi Semiconductor Co. on Thursday announced a plan to retire 130.0 billion won ($90 million) worth of treasury shares in May, marking its largest-...
Feb 13, 2025 (Gmt+09:00)
-
Electronics
Hanmi Semiconductor to build new TC Bonder plant in Incheon
Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, held a ground-breaking ceremony for its seventh plant of...
Jan 07, 2025 (Gmt+09:00)
-
Corporate governance
Hanmi Pharm’s chair poised to win management feud with her son
Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...
Dec 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi breaks ground pharmaceuticals complex in Beijing
South Korea's Hanmi Pharmaceutical Co. said on Friday that Beijing Hanmi Pharm, its subsidiary in China, held the groundbreaking ceremony for a proj...
Dec 06, 2024 (Gmt+09:00)
-
Private equity
La Defense might have a say over Hanmi Pharm's family feud
La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...
Nov 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Nov 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Nov 20, 2024 (Gmt+09:00)
-
Banking & Finance
Hanmi Bank rises from Koreatown lender to regional bank
It began in 1982 as a small community bank for Korean immigrants in Los Angeles, California. Today, Hanmi Bank, under Nasdaq-listed Hanmi Financial ...
Nov 15, 2024 (Gmt+09:00)
-
Korean stock market
MSCI Korea Index adds Hyundai Rotem
MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...
Nov 07, 2024 (Gmt+09:00)
-
Pension funds
NPS signals more say in Hanmi Pharmaceutical's family feud
South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...
Aug 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion scraps merger with Celltrion Pharm
South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn
South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...
Jul 18, 2024 (Gmt+09:00)
-
Corporate governance
Korea’s Hanmi family feud to end as key shareholder mediates
South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...
Jul 11, 2024 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor eyes $1.5 billion sales in 2026
Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, has revised upwards its annual sales target for this yea...
Jul 05, 2024 (Gmt+09:00)
-
Korean chipmakers
Booming AI industry boosts chip packaging equipment makers
Global chip packaging equipment manufacturers are enjoying surging demand and skyrocketing share prices thanks to the rapid growth of the artificial...
Jun 24, 2024 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $110 mn HBM equipment order from SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has received an order from SK Hynix Inc. for its dual TC bon...
Jun 07, 2024 (Gmt+09:00)
-
Corporate governance
Hanmi to fire founder's wife, entering new round of family feud
South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...
May 13, 2024 (Gmt+09:00)
-
Bio & Pharma
KKR, Hanmi heirs likely to join hands for controlling stake
The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...
Apr 02, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Hanmi’s planned merger with OCI scrapped as sons win family feud
Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...
Mar 28, 2024 (Gmt+09:00)
-
Corporate governance
Hanmi Science-OCI merger may gain traction with NPS' support
The merger of South Korea’s pharmaceutical holding firm Hanmi Science Co. and chemicals giant OCI Holdings Co. is likely to gain momentum as N...
Mar 27, 2024 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $16 mn HBM equipment order from SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has secured a 21.5 billion won ($16.1 million) supply deal f...
Mar 22, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Proxy advisor KCGS backs Hanmi founder's sons return to board
South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group&rsquo...
Mar 20, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger faces tougher hurdles amid family feud
Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...
Feb 13, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $31 mn order HBM equipment for SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. said on Friday that it has secured a 41.5 billion won ($31.4 million) deal with SK Hynix...
Sep 01, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google